[go: up one dir, main page]

CL2004000564A1 - PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES ONE OR MORE PHARMACEUTICALLY ACTIVE AGENTS AND COCOA POWDER. - Google Patents

PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES ONE OR MORE PHARMACEUTICALLY ACTIVE AGENTS AND COCOA POWDER.

Info

Publication number
CL2004000564A1
CL2004000564A1 CL200400564A CL2004000564A CL2004000564A1 CL 2004000564 A1 CL2004000564 A1 CL 2004000564A1 CL 200400564 A CL200400564 A CL 200400564A CL 2004000564 A CL2004000564 A CL 2004000564A CL 2004000564 A1 CL2004000564 A1 CL 2004000564A1
Authority
CL
Chile
Prior art keywords
oral administration
active agents
pharmaceutical formulation
pharmaceutically active
cocoa powder
Prior art date
Application number
CL200400564A
Other languages
Spanish (es)
Inventor
Lindberg Katarina Ev Nils-Olof
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of CL2004000564A1 publication Critical patent/CL2004000564A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5777—Theobroma, e.g. cocao or cocoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
CL200400564A 2003-03-26 2004-03-18 PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES ONE OR MORE PHARMACEUTICALLY ACTIVE AGENTS AND COCOA POWDER. CL2004000564A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300831A SE0300831D0 (en) 2003-03-26 2003-03-26 New formulations and use therof

Publications (1)

Publication Number Publication Date
CL2004000564A1 true CL2004000564A1 (en) 2005-02-04

Family

ID=20290786

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400564A CL2004000564A1 (en) 2003-03-26 2004-03-18 PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES ONE OR MORE PHARMACEUTICALLY ACTIVE AGENTS AND COCOA POWDER.

Country Status (13)

Country Link
EP (1) EP1605921A1 (en)
JP (2) JP2006521348A (en)
CN (1) CN1764440A (en)
AR (1) AR043772A1 (en)
AU (1) AU2004224557B2 (en)
BR (1) BRPI0408655A (en)
CA (1) CA2519155A1 (en)
CL (1) CL2004000564A1 (en)
MX (1) MXPA05010196A (en)
SE (1) SE0300831D0 (en)
TW (1) TW200503782A (en)
WO (1) WO2004084865A1 (en)
ZA (1) ZA200507719B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
JP4806507B2 (en) 1999-10-29 2011-11-02 ユーロ−セルティーク エス．エイ． Controlled release hydrocodone formulation
MXPA03003895A (en) 2000-10-30 2003-07-28 Euro Celtique Sa Controlled release hydrocodone formulations.
CN101237850A (en) * 2005-08-02 2008-08-06 德罗萨帕尔姆股份公司 Pharmaceutical composition containing indomethacin and/or acemetacin
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
EP2168440B1 (en) 2007-06-13 2018-03-28 Otsuka Pharmaceutical Co., Ltd. Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
CN101439053A (en) * 2007-11-22 2009-05-27 何煜 Chinese medicine rapid-release preparation for oral cavity and method for producing the same
WO2009070978A1 (en) * 2007-11-22 2009-06-11 Yu He An oral cavity rapid release of the health products and its preparation method
CN101444273B (en) * 2007-11-22 2013-04-24 何煜 Health product oral fast-release preparation and production method thereof
JP2012527406A (en) * 2009-05-20 2012-11-08 リングアル コンセグナ ピーティーワイ エルティーディー Oral and / or sublingual preparations
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
WO2011143120A1 (en) 2010-05-11 2011-11-17 Cima Labs Inc. Alcoholres i stant metoprolol - containing extended - release oral dosage forms
WO2014135967A1 (en) 2013-03-06 2014-09-12 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
CN103583781B (en) * 2013-11-01 2015-11-25 阳波 Caf metronidazole chewing gum
US20170112762A1 (en) * 2014-06-10 2017-04-27 Capsugel Belgium Nv Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
WO2016087261A1 (en) 2014-12-04 2016-06-09 Capsugel Belgium N.V. Lipid multiparticulate formulations
JP6334482B2 (en) * 2015-08-28 2018-05-30 中野Ｂｃ株式会社 Solid agent and production method thereof
MX390001B (en) * 2015-12-09 2025-03-19 Poviva Tea Llc STABLE READY-TO-DRINK BEVERAGE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS.
WO2017100062A1 (en) * 2015-12-09 2017-06-15 Poviva Tea, Llc Methods for formulating orally ingestible compositions comprising lipophilic active agents
JP6568790B2 (en) * 2015-12-18 2019-08-28 Ｔｏｙｏ Ｔｉｒｅ株式会社 Pneumatic tire
WO2018090096A1 (en) * 2016-11-18 2018-05-24 The University Of Western Australia Taste masking product
WO2019166098A1 (en) * 2018-03-01 2019-09-06 Lts Lohmann Therapie-Systeme Ag Oral dosage form containing theobromine-free cocoa
CN109053718B (en) * 2018-08-09 2022-06-03 天津理工大学 A kind of rosiglitazone saccharin salt and preparation method thereof
CN111729087A (en) * 2020-07-24 2020-10-02 成都大学 Lipid modification of a selective β2 receptor agonist and preparation method and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB785574A (en) * 1955-03-29 1957-10-30 Pfizer & Co C Pharmaceutical compositions containing tetracycline antibiotics
GB918955A (en) * 1960-05-19 1963-02-20 Thomae Gmbh Dr K Pharmaceutical laxative compositions comprising 4,4-dihydroxy-2-amino triphenylmethane
FR2717387B1 (en) * 1994-03-17 1996-10-18 Hi Pharmtech Process for the production of chewable tablets based on troxerutin, calcium carbonate, calcium phosphate, arginine aspartate, amoxicillin arginine glutamate.
SE9803986D0 (en) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
JP2001106641A (en) * 1999-10-06 2001-04-17 Tendou Seiyaku Kk Intraoral medicine
JP2001114668A (en) * 1999-10-13 2001-04-24 Meiji Seika Kaisha Ltd Chocolate preparation
JP2002193839A (en) * 2000-12-27 2002-07-10 Meiji Seika Kaisha Ltd Cocoa pharmaceutical preparation
US20020172732A1 (en) * 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa
SE0103211D0 (en) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof

Also Published As

Publication number Publication date
JP2006521348A (en) 2006-09-21
AU2004224557B2 (en) 2009-06-18
CA2519155A1 (en) 2004-10-07
EP1605921A1 (en) 2005-12-21
SE0300831D0 (en) 2003-03-26
JP2011079841A (en) 2011-04-21
CN1764440A (en) 2006-04-26
BRPI0408655A (en) 2006-03-28
AU2004224557A1 (en) 2004-10-07
WO2004084865A1 (en) 2004-10-07
ZA200507719B (en) 2007-09-26
AR043772A1 (en) 2005-08-10
MXPA05010196A (en) 2005-11-08
TW200503782A (en) 2005-02-01

Similar Documents

Publication Publication Date Title
CL2004000564A1 (en) PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES ONE OR MORE PHARMACEUTICALLY ACTIVE AGENTS AND COCOA POWDER.
HUP0500846A3 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
NO20043702L (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
CY2011013I1 (en) SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING AN S1P RECEPTOR AGENT AND A SUGAR ALCOHOL
DK1498411T3 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
ATE354362T1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHIC ACTIVE INGREDIENT
ITMI20011337A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF THE ACTIVE INGREDIENT
HUE040046T2 (en) Methods of administering pharmaceutical compositions and drugs
NO20043904L (en) Oral dosage form containing an active ingredient PDE4 inhibitor and polyvinylpyrrolidone as the excipient
IL216931A0 (en) Pharmaceutical formulation that comprisies azelastine and fluticasone and aproduct comprising these as antihistamine and anti - inflammatory agent
NO20054244D0 (en) Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
EP1513825A4 (en) ANTI-TUBERCULOUS DRUG: COMPOSITIONS AND METHODS
DK1557415T3 (en) Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
ZA200605631B (en) Directly compressible pharmaceutical composition for the oral administration of CCI-779
DE60020501D1 (en) Trimetazidine-containing matrix tablet for prolonged release of active ingredient after oral administration
PT1210119E (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL AND TOPIC ADMINISTRATION
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
ITMI20011338A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
EP1501352A4 (en) METHODS AND COMPOSITIONS FOR CONTROLLED DELIVERY OF DRUGS
NO20026055L (en) Pharmaceutical Components Including Human Parathyroid Hormone And Pharmaceutical Compositions For Nasal Administration Containing The Components
IL173847A0 (en) Pharmaceutical composition in a form of anhydrous self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
PL1655026T3 (en) Solid pharmaceutical formulations comprising diacereine and meloxicam